Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127965711 | 12796571 | 1 | I | 20160925 | 20160929 | 20160929 | EXP | PR-PFIZER INC-2016451365 | PFIZER | 75.00 | YR | F | Y | 82.00000 | KG | 20160929 | CN | PR | PR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127965711 | 12796571 | 1 | PS | PREMARIN | ESTROGENS, CONJUGATED | 1 | UNK | D | JI8270 | 20216 | VAGINAL CREAM | ||||||||
| 127965711 | 12796571 | 2 | C | IRBESARTAN. | IRBESARTAN | 1 | 150/12.5 MG | 0 | |||||||||||
| 127965711 | 12796571 | 3 | C | IRBESARTAN AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDEIRBESARTAN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127965711 | 12796571 | 1 | Vulvovaginal dryness |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127965711 | 12796571 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127965711 | 12796571 | Drug ineffective | |
| 127965711 | 12796571 | Expired product administered | |
| 127965711 | 12796571 | Hypertension | |
| 127965711 | 12796571 | Vulvovaginal injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |